Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs Vanguard High Dividend Yield ETF (VYM) Price & Performance

CVS Health CorpTrade
Vanguard High Dividend Yield ETFTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs Vanguard High Dividend Yield ETF — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.49B), while Vanguard High Dividend Yield ETF trades at $158.5 (market cap $100.80B). The key difference: CVS Health Corp and Vanguard High Dividend Yield ETF are close in size by market cap, and CVS Health Corp pays a 3.02% dividend while Vanguard High Dividend Yield ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Vanguard High Dividend Yield ETF for 138 Days on average.

CVSVYM
Market Cap
$112.49B$100.80B
Volume
8,467,392993,696
Sector
Health—
52-Week High
$110.60$167.03
52-Week Low
$70.08$137.47
Typical Hold Time
83 Days138 Days
Enterprise Value
$174.83B—
Dividend Yield
3.02%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.

CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.

Vanguard High Dividend Yield ETF

VYM trades at $157.45, down 0.58% on the day, with a bearish technical signal from moving averages while oscillators remain neutral. The ETF's 2.42% yield provides consistent income, though recent articles highlight performance comparisons with peers like SCHD and IDV. Support and resistance levels cluster tightly around $157-158, indicating potential for near-term price consolidation.

The outlook remains cautious as VYM faces competitive pressure from higher-yielding alternatives and concerns about dividend sustainability in its holdings. While diversification and low costs are strengths, investors should weigh the trade-offs between yield consistency and total return potential in the current market environment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVS

No sentiment data available yet.

VYM
32% Buy68% Sell
Avg holding period · 138 Days

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS →

About Vanguard High Dividend Yield ETF

The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Read more on VYM →